QURE – uniqure n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
uniQure (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
uniQure (NASDAQ: QURE) had its price target lowered by analysts at Wells Fargo & Company from $35.00 to $30.00. They now have an "equal weight" rating on the stock.
uniQure Announces 2024 Financial Results and Highlights Recent Company Progress
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B
Form 4 uniQure N.V. For: Mar 03 Filed by: Kapusta Matthew C
Form 4 uniQure N.V. For: Mar 03 Filed by: Abi-Saab Walid
Form 4 uniQure N.V. For: Mar 03 Filed by: KLEMT CHRISTIAN
Form 4 uniQure N.V. For: Mar 03 Filed by: Potts Jeannette
Form 4 uniQure N.V. For: Feb 25 Filed by: Kapusta Matthew C
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.